Theodore Alan Huizenga, SVP, Chief Accounting Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 91 shares at $56.19 ($5K) on 2024-09-03, disclosed to the SEC on 2024-09-05.
Open-market sale of $5k RARE by SVP, Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RARE | SELL | 2026-03-03 | $37K | — | Filing → |
| RARE | SELL | 2025-12-30 | $3K | — | Filing → |
| RARE | SELL | 2025-09-19 | $2K | — | Filing → |